Invuity Announces Proposed Public Offering of Common Stock
July 27 2016 - 4:01PM
Invuity, Inc. (NASDAQ:IVTY) ("Invuity" or the "Company"), a leading
surgical photonics company, today announced that it intends to
offer and sell, subject to market and other conditions, shares of
its common stock in an underwritten public offering. Invuity
expects to grant the underwriters a 30-day option to purchase
additional shares of its common stock.
Invuity intends to use the net proceeds from the offering for
continued expansion of its sales and marketing activities,
investments in research and development, potential acquisitions or
investments in complementary products, technologies or businesses,
and working capital and other general corporate purposes.
Piper Jaffray & Co. and Leerink Partners LLC are acting as
joint book-running managers for the offering. William Blair
& Company, L.L.C. is acting as a co-manager for the
offering.
The offering is being made pursuant to an effective shelf
registration statement on Form S-3 (No. 333-212395) that was
initially filed with the U.S. Securities and Exchange Commission
(the "SEC") on July 1, 2016. A preliminary prospectus supplement
describing the terms of the offering will be filed with the SEC and
will form a part of the effective registration statement and will
be available on the SEC's website located at www.sec.gov. When
available, copies of the preliminary prospectus supplement and the
accompanying prospectus relating to the offering may be obtained
from the offices of Piper Jaffray & Co., Attention: Prospectus
Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, or by
e-mail at prospectus@pjc.com or by telephone at (800) 747-3924 or
Leerink Partners LLC, Attention: Syndicate Department, One Federal
Street, 37th Floor, Boston, MA 02110, or by e-mail at
Syndicate@Leerink.com or by telephone at (800) 808-7525 ext.
6142.
This press release shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of
these securities in any state or jurisdiction in which such offer,
solicitation or sale would be unlawful prior to registration or
qualification under the securities laws of any such state or
jurisdiction.
About Invuity®
Invuity, Inc. is a medical technology company focused on
developing and marketing advanced photonics devices to improve the
ability of surgeons to illuminate and visualize the surgical cavity
during open minimally invasive and minimal access surgery. The
Company's patented Intelligent Photonics™ technology enables
enhanced surgical precision, efficiency and safety by providing
superior visualization. Clinical applications include breast and
thyroid oncology, plastic reconstructive, spine, orthopedic,
cardiothoracic and general surgery among others. Invuity is
headquartered in San Francisco, CA.
Forward-Looking Statements
This announcement contains forward-looking statements within the
meaning of the Securities Act of 1933, as amended, the Securities
Exchange Act of 1934, as amended, and the Private Securities
Litigation Reform Act of 1995. These forward-looking statements,
including statements regarding the proposed public offering and the
anticipated use of proceeds therefrom, are subject to a number of
risks and uncertainties which may cause actual results or outcomes
to be materially different from those expressed or implied by the
forward-looking statements. These risks and uncertainties include
market risks and uncertainties and risks and uncertainties relating
to the satisfaction of customary closing conditions for an
underwritten offering of securities, as well as the risks and
uncertainties that could affect the Company's business and
financial results described in the preliminary prospectus
supplement and registration statement referenced above, as well as
the Company’s other filings with the SEC, including, without
limitation, under the caption "Risk Factors." There can be no
assurance that the Company will be able to complete the proposed
public offering on the anticipated terms, or at all.
Forward-looking statements relate only to events as of the date on
which the statements are made, and the Company undertakes no
obligation to publicly update or review any forward-looking
statement.
CONTACT:
Company Contact:
Jim Mackaness
Chief Financial Officer
Invuity, Inc.
415-655-2129
Investors:
Mark Klausner
Westwicke Partners
443-213-0501
irdept@invuity.com
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jun 2024 to Jul 2024
INVUITY, INC. (NASDAQ:IVTY)
Historical Stock Chart
From Jul 2023 to Jul 2024